From Preadipocyte to Adipocyte: Differentiation-Directed Signals of Insulin from the Cell Surface to the Nucleus

References

• Sigal RJ, Warram JH. The interaction between obesity and diabetes. Curr Opin Endocrinol Diabetes 1996; 3: 3–9.
   Google Scholar
• Kuczmarski RJ, Flegal KM, Campbell SM, et al. Increasing prevalence of overweight among US adults. The National Health and Nutrition Surveys, 1960-1991. JAMA 1994; 272: 205–211.
   Google Scholar
• Macdonald SM, Reeder BA, Chen Y, et al. Obesity in Canada: a descriptive analysis. Can Med Assoc J 1997; 157: S3–S9.
   Google Scholar
• Centers for Disease Control. Daily dietary fat and total food-energy intakes: third National Health and Nutrition Examination Survey, phase 1, 1988-91. Morbid Mortal Wkly Rep 1994; 43: 116–125.
   PubMedGoogle Scholar
• Zachwieja JJ. Exercise as treatment for obesity. Endocrinol Metab Clin N Amer 1996; 25: 965–988.
   Google Scholar
• Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677–685.
   PubMed Web of Science ®Google Scholar
• Bray GA. Health hazards of obesity. Endocrinol Metab Clin N Amer 1996; 25: 907–919
   PubMed Web of Science ®Google Scholar
• Gortmaker SL, Must A, Perrin JM, et al. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 1993; 329: 1008–1012.
   PubMed Web of Science ®Google Scholar
• Rosenbaum, M, Leibel RL Hirsch J. Obesity N Engl J Med 1997; 337: 396–406.
   PubMed Web of Science ®Google Scholar
• Bjorntorp P. “Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990; 10: 493–496.
   PubMedGoogle Scholar
• Reaven GM. Role of insulin resistance in human disease (Syndrome X): an expanded definition. Annu Rev Medicine 1993; 44: 121–131.
   PubMed Web of Science ®Google Scholar
• Despres JP, Moorjani S, Lupien PJ, et al. Regional distribution of body fat, plasma lipopro-teins, and cardiovascular disease. Arteriosclerosis 1990; 10: 497–511.
   PubMedGoogle Scholar
• Reaven GM, Lithell H Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374–381.
   PubMed Web of Science ®Google Scholar
• Bouchard C, Despres J-P Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocrinol Rev 1993; 14: 72–93.
   PubMed Web of Science ®Google Scholar
• Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952–957.
   PubMed Web of Science ®Google Scholar
• Hsueh W, Law RE, Saad M, et al. Insulin resistance and macrovascular disease. Curr Opin Endocrinol Diabetes 1996; 3: 346–354.
   Google Scholar
• Hotamisligil GS, Shargill NS Spiegelman BM. Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409–2415.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffel M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425–432.
   PubMed Web of Science ®Google Scholar
• Shimabukuro M, Koyama K, Chen G, et al. Direct antidiabetic effect of leptin through trig-lyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94: 4637–4641.
   PubMed Web of Science ®Google Scholar
• Shen GX, Angel A. Regulation of cholesterol ester transfer activity in adipose tissue: comparison between hamster and rat species. Am J Physiol 1995; 269: E99–107.
   Google Scholar
• Radeau T, Lau P, Robb M, et al. Cholesterol ester transfer protein (CETP) mRNA abundance in human adipose tissue relationship to cell size and membrane cholesterol content. J Lipid Res 1995; 36: 2552–2561.
   Google Scholar
• Frederich RC Jr, Kahn BB, Peach MJ et al. Tissue-specific nutritional regulation of angio-tensinogen in adipose tissue. Hypertension 1992; 19: 339–344.
   PubMed Web of Science ®Google Scholar
• Hu E, Liang P Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697–10703.
   PubMed Web of Science ®Google Scholar
• Rosen BS, Cook KS, Yaglom J, et al. Adipsin and complement factor D activity: an immune-related defect in obesity. Science 1989; 244: 1483–1487.
   PubMed Web of Science ®Google Scholar
• Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746–26749.
   PubMed Web of Science ®Google Scholar
• Baldo A, Sniderman AD, St. Luce S, et al. The adipsin/acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 1993; 92: 1543–1547.
   PubMed Web of Science ®Google Scholar
• Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Medicine 1996; 2: 800–803.
   PubMed Web of Science ®Google Scholar
• Juhan-Vague I, Alessi MC Vague P. Increased plasminogen activator inhibitor I levels: a possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457–462.
   PubMed Web of Science ®Google Scholar
• Curfman GD. Diet pills redux. N Engl J Med 1997; 337: 629–630.
   PubMed Web of Science ®Google Scholar
• NIH Health Technology Assessment Conference Panel. Methods for voluntary weight loss and control. Ann Intern Med 1992; 116: 942–949.
   Google Scholar
• Eckel RH. Lipoprotein lipase. N Engl J Med 1989; 320: 1060–1068.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Yost TJ. Weight reduction increases adipose tissue lipoprotein lipase responsiveness in obese women. J Clin Invest 1987; 80: 992–997.
   PubMedGoogle Scholar
• Schwartz R, Brunzell JD. Increase of adipose tissue lipoprotein lipase activity with weight loss. J Clin Invest 1981; 67: 1425.
   PubMed Web of Science ®Google Scholar
• Hirsch J, Fried SK, Edens NK, et al. The fat cell. Med Clin N Am 1989; 73: 83–96.
   PubMed Web of Science ®Google Scholar
• Bougneres P, Le Stunff C, Pecqueur C, et al. In vivo resistance of lipolysis to epinephrine. J Clin Invest. 1997; 99: 2568–2573.
   PubMed Web of Science ®Google Scholar
• Ailhaud G, Grimaldi P, Negrel R. Hormonal regulation of adipose differentiation. Trends Endocrinol Metab 1994; 5: 132–136.
   Google Scholar
• Shillabeer G, Forden JM, Lau DCW. Induction of preadipocyte differentiation by mature fat cells in the rat. J Clin Invest 1989; 84: 381–387.
   Google Scholar
• Kim JB, Sarraf P, Wright M, et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest 1998; 101: 1–9.
   PubMed Web of Science ®Google Scholar
• Brun RP, Kim JB, Hu E, et al. Adipocyte differentiation: a transcriptional regulatory cascade. Curr Opin Cell Biol 1996; 8: 826–832.
   Google Scholar
• Amri EZ, Bertrand B, Ailhaud G, et al. Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J Lipid Res 1991, 32: 1449–1456.
   PubMed Web of Science ®Google Scholar
• Klaus S. Functional differentiation of white and brown adipocytes. BioEssays 1997; 19: 215–223.
   PubMed Web of Science ®Google Scholar
• Cornelius P, MacDougald OA, Lane MD. Regulation of adipocyte development. Annu Rev Nutr 1994; 14: 99–129.
   PubMed Web of Science ®Google Scholar
• Dani C, Smith AG, Dessolin S, et al. Differentiation of embryonic stem cells into adipo-cytes in vitro. J Cell Sci 1997; 110: 1279–1285.
   PubMed Web of Science ®Google Scholar
• Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 1992; 12: 207–233.
   PubMed Web of Science ®Google Scholar
• Smas CM, Sul HS. Control of adipocyte differentiation. Biochem J 1995; 309: 697–710.
   PubMed Web of Science ®Google Scholar
• MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipo-cyte differentiation. Annu Rev Biochem 1995; 64: 345–373.
   PubMed Web of Science ®Google Scholar
• Lemonnier D. Effect of age, sex, and site on the cellularity of the adipose tissue in mice and rats rendered obese by a high-fat diet. J Clin Invest 1972; 51: 2907–2912.
   PubMed Web of Science ®Google Scholar
• Faust IM, Johnson PR, Stern JS, et al. Diet-induced adipocyte number increase in adult rats: a new model of obesity. Am J Physiol 1978; 235: E279–E286.
   PubMed Web of Science ®Google Scholar
• Ochi M, Yoshioka H, Sawada T, et al. New adipocyte formation in mice during refeeding after long-term deprivation. Am J Physiol 1991; 260: R468–R474.
   Google Scholar
• Shepherd PR, Gnudi L, Tozzo E, et al. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 1993; 268: 22243–22246.
   PubMed Web of Science ®Google Scholar
• Hirsch J, Batchelor B. Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 1976; 5: 299–311.
   PubMedGoogle Scholar
• Poznanski WJ, Waheed I, Van R. Human fat cell precursors. Laboratory Invest 1973; 29: 570–576.
   PubMed Web of Science ®Google Scholar
• Van RLR, Bayliss CE, Roncari DAK. Cytological and enzymological characterization of adult human adipocyte precursors in culture. J Clin Invest 1976; 58: 699–704.
   PubMed Web of Science ®Google Scholar
• Hauner H, Entenmann G, Wabitsch M, et al. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 1989; 84: 1663–1670.
   PubMed Web of Science ®Google Scholar
• Roncari DAK. Pre-adipose cell replication and differentiation. Trends Biochem Sci 1984; 9: 486–489.
   Google Scholar
• Sugihara H, Funatsumaru S, Yonemitzu N, et al. A simple culture method of fat cells from mature fat tissue fragments. J Lipid Res 1989; 30: 1987–1995.
   PubMed Web of Science ®Google Scholar
• Carraro R, Li ZH, Johnson JE Jr, et al. Islets of preadipocytes highly committed to differentiation in cultures of adherent rat adipocytes. Cell Tissue Res 1991; 264: 243–251.
   Google Scholar
• Entenmann G, Hauner H. Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am J Physiol 1996; 270: C1011–C1016.
   PubMedGoogle Scholar
• Green H, Kehinde O. Sublines of mouse 3T3 cells that accumulate lipid. Cell 1974; 1: 113–116.
   Web of Science ®Google Scholar
• Novikoff AB, Novikoff PM, Rosen OM. Organelle relationships in cultured 3T3-L1 pread-ipocytes. J Cell Biol 1980; 87: 180–196.
   PubMed Web of Science ®Google Scholar
• Green H, Kehinde O. Formation of normally differentiated subcutaneous fat pads by an established preadipose cell line. J Cell Physiol 1979; 101: 169–172.
   PubMed Web of Science ®Google Scholar
• Mandrup S, Loftus TM, MacDougald OA, et al. Obese gene expression at in vitro levels by fat pads derived from s.c. implanted 3T3-F442A preadipocytes. Proc Natl Acad Sci USA 1997; 94: 4300–4305.
   PubMed Web of Science ®Google Scholar
• Gaillard D, Poli P, Negrel R. Characterization of ouabain-resistant mutants of the preadi-pocyte Ob17 clonal cell line. Exp Cell Res 1985, 156: 513–527.
   Google Scholar
• Mandrup S, Lane MD. Regulating adipogenesis. J Biol Chem 1997; 272: 5367–5370.
   PubMed Web of Science ®Google Scholar
• Shao D, Lazar MA. Peroxisome proliferator activated receptor g, CCAT/Enhancer-binding protein a, and cell cycle status regulate the commitment to adipocyte differentiation. J Biol Chem 1997; 272: 21473–21478.
   PubMed Web of Science ®Google Scholar
• Lin FT, Lane MD. CCAAT/enhancer binding protein a is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 1994; 91: 8757–8761.
   PubMed Web of Science ®Google Scholar
• Wang N, Finegold MJ, Bradley A, et al. Impaired energy homeostasis in C/EBPa knockout mice. Science 1995; 269: 1108–1112.
   PubMed Web of Science ®Google Scholar
• Yeh WC, McKnight SL. Regulation of adipose maturation and energy homeostasis. Curr Opin Cell Biol 1995; 7: 885–890.
   Google Scholar
• Wu Z, Bucher NLR, Farmer SR. Induction of peroxisome proliferator-activated receptor g during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPb, C/EBPd, and glucocorticoids. Mol Cell Biol 1996; 16: 4128–4136.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARg2, a lipid-activated transcription factor. Cell 1994; 79: 1147–1156.
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Lenhard JM, Willson TM, et al. A prostaglandin J2 metabolite binds peroxi-some proliferator-activated receptor g and promotes adipocyte differentiation. Cell 1995; 83: 813–819.
   PubMed Web of Science ®Google Scholar
• Forman BM, Tontonoz P, Chen J, et al. 15-deoxy-D12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARg. Cell 1995; 83: 803–812.
   PubMed Web of Science ®Google Scholar
• Lehmann JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic thiazolinedione is a high affinity ligand for peroxisome proliferator-activated receptor g (PPARg). J Biol Chem 1995; 270: 12953–12956.
   PubMed Web of Science ®Google Scholar
• Kletzien RF, Clark SD, Ulrich RG. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol Pharmacol 1992; 41: 393–398.
   PubMed Web of Science ®Google Scholar
• Reginato MJ, Krakow SL, Bailey ST, et al. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor g. J Biol Chem 1997; 273: 1855–1858.
   Google Scholar
• Nolan JJ, Ludvik B, Beerdsen P, et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994; 331: 1188–1193.
   PubMed Web of Science ®Google Scholar
• Smith PJ, Wise LS, Berkowitz R, et al. Insulin-like growth factor-1 is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 1988; 263: 9402–9408.
   PubMed Web of Science ®Google Scholar
• Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocrinol Rev 1995; 16: 117–142.
   PubMed Web of Science ®Google Scholar
• Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993; 55: 131–153.
   PubMed Web of Science ®Google Scholar
• Rubin CS, Hirsch A, Fung C, et al. Development of hormone receptors and hormonal responsiveness in vitro. J Biol Chem 1978; 253: 7570–7578.
   PubMed Web of Science ®Google Scholar
• Accili D, Taylor SI. Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 fi-broblasts via homologous recombination. Proc Natl Acad Sci USA 1991; 88: 4708–4712.
   PubMed Web of Science ®Google Scholar
• Chaika OV, Chaika N, Volle DJ, et al. CSF-1 receptor/insulin receptor chimera permits CSF-1-dependent differentiation of 3T3-L1 preadipocytes. J Biol Chem 1997; 272: 11968–11974.
   PubMed Web of Science ®Google Scholar
• Gagnon AM, Sorisky A. The effect of glucose concentration on insulin-induced 3T3-L1 adipose cell differentiation. Obesity Res 1998; in press.
   Google Scholar
• Hauner H. Complete adipose differentiation of 3T3-L1 cells in a chemically defined medium: comparison to serum-containing culture conditions. Endocrinology 1990; 127: 865–872.
   PubMedGoogle Scholar
• Olefsky JM. Insulin resistance in non-insulin-dependent diabetes mellitus. Curr Opin En-docrinol Diabetes 1995; 2: 290–299.
   Google Scholar
• Schubert C, Carel K, DePaola D, et al. Interactions of protein kinase C with insulin signaling. J Biol Chem 1996; 271: 15311–15314.
   PubMedGoogle Scholar
• American Type Culture Collection, 1993; Product Sheet CCL 92.1.
   Google Scholar
• Myers MG Jr, White MF. New frontiers in insulin receptor substrate signaling. Trends En-docrinol Metab 1995; 6: 209–215.
   Google Scholar
• Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997; 278: 2075–2080.
   PubMed Web of Science ®Google Scholar
• Sun XJ, Wang LM, Zhang Y, et al. Role of IRS-2 in insulin and cytokine signaling. Nature 1995; 377: 173–177.
   PubMed Web of Science ®Google Scholar
• Sun XJ, Pons S, Wang LM, et al. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol Endocrinol 1997; 11: 251–262.
   PubMed Web of Science ®Google Scholar
• Lavan BE, Lane WS, Lienhard GE. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 1997; 272: 11439–11443.
   PubMed Web of Science ®Google Scholar
• Lavan BE, Fantin VR, Chang ET, et al. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 1997; 272: 21403–21407.
   PubMed Web of Science ®Google Scholar
• Saad MJA, Folli F, Araki E, et al. Regulation of insulin receptor, insulin receptor sub-strate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone. Mol Endocrinol 1994; 8: 545–557.
   Google Scholar
• Hu Q, Klippel A, Muslin AJ, et al. Ras-dependent induction of cellular responses by con-stitutively active phosphatidylinositol 3-kinase. Science 1995; 268: 100–102.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Viciana P, Warne PH, Dhand R. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994; 370: 527–532.
   PubMed Web of Science ®Google Scholar
• Hall A. Ras-related proteins. Curr Opin Cell Biol 1993; 5: 265–268.
   PubMedGoogle Scholar
• Egan SE, Weinberg RA. The pathway to signal achievement. Nature 1993; 365: 781–783.
   PubMed Web of Science ®Google Scholar
• Bar-Sagi D. The Sos (Son of sevenless) protein. Trends Endocrinol Metab 1994; 5: 165–169.
   Google Scholar
• Cantley LC, Auger KR, Carpenter C, et al. Oncogenes and signal transduction. Cell 1991; 64: 281–302.
   PubMed Web of Science ®Google Scholar
• Gibbs JB, Oliff A Kohl NE. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 1994; 77: 175–178.
   PubMed Web of Science ®Google Scholar
• Hall A. A biochemical function for Ras — at last. Science 1994; 264: 1413–1414.
   PubMed Web of Science ®Google Scholar
• Benito M, Porras A, Nebreda AR, et al. Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes. Science 1991; 253: 565–568.
   PubMedGoogle Scholar
• Porras A, Nebreda AR, Benito M, et al. Activation of Ras by insulin in 3T3-L1 cells does not involve GTPase-activating protein phosphorylation. J Biol Chem 1992; 267: 21124–21131.
   PubMedGoogle Scholar
• Porras A, Muszynski K., Rapp UR, et al. Dissociation between activation of Raf-1 kinase and the 42-kDa mitogen-activated protein kinase/90-kDa S6 kinase (MAPK/RSK) cascade in the insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells. J Biol Chem 1994; 269: 12741–12748.
   PubMedGoogle Scholar
• Demora J, Porras A, Ahn N, et al. Mitogen-activated protein kinase activation is not nece-saary for, but antagonizes, 3T3-L1 adipocytic differentiation. Mol Cell Biol 1997; 17: 6068–6075.
   Google Scholar
• Hu E, Kim JB, Sarraf P, et al. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARg. Science 1996; 274: 2100–2103.
   PubMed Web of Science ®Google Scholar
• Sale EM, Atkinson PGP Sale GJ. Requirement of MAP kinase for differentiation of fibro-blasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J 1995; 14: 674–684.
   PubMed Web of Science ®Google Scholar
• Tomiyama K, Nakata, H, Sasa H, et al. Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 1995; 212: 263–269.
   PubMed Web of Science ®Google Scholar
• Magun R, Burgering BMT, Coffer P, et al. Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 1996; 137: 3590–3593.
   PubMed Web of Science ®Google Scholar
• Carpenter CL, Cantley LC. Phosphoinositide kinases. Curr Opin Cell Biol 1996; 8: 153–158.
   PubMed Web of Science ®Google Scholar
• Stephens LR, Hughes KT, Irvine RF. Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils. Nature 1991; 351: 33–39.
   PubMed Web of Science ®Google Scholar
• Hawkins PT, Jackson TR Stephens LR. Platelet-derived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activating a PtdIns(4,5)P2 3-OH kinase. Nature 1992; 358: 157–159.
   PubMed Web of Science ®Google Scholar
• Irvine RF. Inositol lipids in cell signaling. Curr Opin Cell Biology 1992; 4: 212–219.
   Google Scholar
• Serunian LA, Haber MT, Fukui T, et al. Polyphosphoinositides produced by phosphatidyli-nositol 3-kinase are poor substrates for phospholipase C from rat liver and bovine brain. J Biol Chem 1989; 264: 17809–17815.
   Google Scholar
• Toker A, Cantley LC. Signaling through the lipid products of phosphoinositide-3-OH kinase. Nature 1997; 387: 673–676.
   PubMed Web of Science ®Google Scholar
• Kapeller R, Cantley LC. Phosphatidylinositol 3-kinase. BioEssays 1994; 16: 565–576.
   PubMed Web of Science ®Google Scholar
• Dhand R, Hara K, Hiles I, et al. PI 3-kinase: structural and functional analysis of intersub-unit interactions. EMBO J 1994; 13: 511–521.
   PubMedGoogle Scholar
• Vanhaesebroeck B, Leevers SJ, Panayoyou G, et al. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem Sci 1997; 22: 267–272.
   PubMed Web of Science ®Google Scholar
• Guinebault C, Payrastre B, Racaud-Sultan C, et al. Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85a with actin filaments and focal adhesion kinase. J Cell Biol 1995; 129: 831–842.
   PubMed Web of Science ®Google Scholar
• Hunter T. When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 1995; 83: 1–4.
   PubMed Web of Science ®Google Scholar
• Dhand R, Hiles I, Panayotou G, et al. PI 3-kinase is a dual specificity enzyme: autoregula-tion by an intrinsic protein-serine kinase activity. EMBO J 1994; 13: 522–533.
   PubMed Web of Science ®Google Scholar
• Lam K, Carpenter CL, Ruderman NB, et al. J Biol Chem 1994; 269: 20648–20652.
   PubMed Web of Science ®Google Scholar
• Sorisky A, Pardasani D Lin Y. The 3-phosphorylated phosphoinositide response of 3T3-L1 preadipose cells exposed to insulin, insulin-like growth factor-1, or platelet-derived growth factor. Obesity Res 1996; 4: 9–19.
   Google Scholar
• Ui M, Okada T, Hazeki K, et al. Wortmannin as a unique probe for an intracellular signaling protein, phosphoinositide 3-kinase. Trends Biochem Sci 1995; 20: 303–307.
   PubMed Web of Science ®Google Scholar
• Chou MM, Blenis J. The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signaling. Curr Opin Cell Biol 1995; 7: 806–814.
   PubMedGoogle Scholar
• Yeh WC, Bierer BE, McKnight SL. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci USA 1995; 92: 11086–11090.
   PubMed Web of Science ®Google Scholar
• Downward J. Lipid-regulated kinases: some common themes at last. Science 1998; 279: 673–674.
   PubMedGoogle Scholar
• Abel ED, Houseknecht KL, Kahn BB. Recent advances in understanding the molecular basis for insulin-stimulated glucose transport. Curr Opin Endocrinol Diabetes 1995; 2: 313–324.
   Google Scholar
• Birnboim MJ, James DE. The insulin-regulatable glucose transporter GLUT-4. Curr Opin Endocrinol Diabetes 1995; 2: 383–391.
   Google Scholar
• Coffer PJ, Woodgett JR. Molecular cloning and characterization of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur J Biochem 1991; 201: 475–481.
   PubMedGoogle Scholar
• Bellacosa A, Testa JR, Staal SP, et al. A retroviral oncogene, akt, encoding a serine-threo-nine kinase containing an SH2-like domain. Science 1991; 254: 274–277.
   PubMed Web of Science ®Google Scholar
• Jones PF, Jakubowicz T, Pitossi FJ, et al. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA 1991; 88: 4171–4175.
   PubMed Web of Science ®Google Scholar
• Andjelkovic M, Alessi DR, Meier R, et al. Role of translocation in the activation and function of protein kinase B. J Biol Chem 1997; 272: 31515–31524.
   PubMed Web of Science ®Google Scholar
• Marte BM, Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 1997; 22: 355–358.
   PubMed Web of Science ®Google Scholar
• Burgering BMT, Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995; 376: 599–602.
   PubMed Web of Science ®Google Scholar
• Franke TF, Yang SI, Chan TO, et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995; 81: 727–736.
   PubMed Web of Science ®Google Scholar
• Kohn AD, Kovacina KS Roth, RA. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J 1995; 14: 4288–4295.
   PubMedGoogle Scholar
• Konishi H, Kuroda S, Kikkawa, U. The pleckstrin homology domain of Rac protein kinase associates with the regulatory domain of protein kinase Cz. Biochem Biophys Res Commun 1994; 205: 1770–1775.
   PubMedGoogle Scholar
• Konishi H, Matsuzaki H, Tanaka M, et al. Proc Natl Acad Sci USA 1996; 93: 7639–7643.
   PubMed Web of Science ®Google Scholar
• Stokoe D, Stephens LR, Copeland T, et al. Dual role of phosphatidylinositol-3,4,5-trispho-sphate in the activation of protein kinase B. Science 1997; 277: 567–570.
   PubMed Web of Science ®Google Scholar
• Klippel A, Kavanaugh WM, Pot D, et al. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol Cell Biol 1996; 17: 338–344.
   Google Scholar
• Stephens L, Anderson K, Stokoe D, et al. Protein kinase B kinases that mediate phosphati-dylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 1998; 279: 710–714.
   PubMed Web of Science ®Google Scholar
• Kohn AD, Summers SA, Birnbaum MJ, et al. Expression of a constitutively active Akt ser/thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996; 271: 31372–31378.
   PubMed Web of Science ®Google Scholar
• Pullen N, Dennis PB, Andjelkovic M, et al. Phosphorylation and activation of p70sK by PDK1. Science 1998; 279: 707–710.
   PubMed Web of Science ®Google Scholar
• Cross DAE., Alessi DR, Cohen P, et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378: 785–789.
   PubMed Web of Science ®Google Scholar
• Franke TF, Cantley LC. A Bad kinase makes good. Nature 1997; 390: 116–117.
   PubMed Web of Science ®Google Scholar
• Dudek H, Datta SR, Franke TF, et al. Regulation of neuronal survival by the serine-threo-nine protein kinase Akt. Science 1997; 275: 661–665.
   PubMed Web of Science ®Google Scholar
• Wijkander J, Landstrom TR, Manganiello V, et al. Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase. Endocrinology 1998; 139: 219–227.
   PubMed Web of Science ®Google Scholar
• Benjamin WB, Pentyala SN, Woodgett JR, et al. ATP citrate-lyase and glycogen synthase kinase-3b in 3T3-L1 cells during differentiation into adipocytes. Biochem J 1994; 1994: 477–482.
   Google Scholar
• de Groot RP, Ballou LM Sassone-Corsi P. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase. Cell 1994; 79: 81–91.
   PubMed Web of Science ®Google Scholar
• Downward J. Regulating S6 kinase. Nature 1994; 371: 378–379.
   Google Scholar
• de Groot RP, Auwerx J Sassone-Corsi P. Negative regulation of Jun/AP-1. Oncogene 1993; 8: 841–847.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kahn CR. Insulin stimulates phosphorylation of c-Jun, c-Fos and Fos-related proteins in cultured adipocytes. J Biol Chem 1994; 269: 11887–11892.
   PubMedGoogle Scholar
• Spiegelman BM, Farmer SR. Decreases in tubulin and actin gene expression prior to morphological differentiation of 3T3 adipocytes. Cell 1982; 29: 53–60.
   PubMed Web of Science ®Google Scholar
• Kuri-Harcuch W, Wise LS Green H. Interruption of the adipose conversion of 3T3 cells by biotin deficiency: differentiation without triglyceride accumulation. Cell 1978; 14: 53–59.
   PubMed Web of Science ®Google Scholar
• Spiegelman BM, Ginty CA. Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell 1983; 35: 657–666.
   PubMed Web of Science ®Google Scholar
• Franke WW, Hergt M Grund C. Rearrangement of the vimentin cytoskeleton during adipose conversion: formation of an intermediate filament cage around lipid globules. Cell 1987; 49: 131–141.
   PubMed Web of Science ®Google Scholar
• Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995; 268: 233–239.
   PubMed Web of Science ®Google Scholar
• Ignotz RA, Massague J. Type b transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc Natl Acad Sci USA 1985; 82: 8530–8534.
   PubMed Web of Science ®Google Scholar
• Ignotz RA, Massague J. Transforming growth factor-b stimulates the expression of fi-bronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337–4345.
   PubMed Web of Science ®Google Scholar
• Smas CM, Sui HS. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993; 73: 725–734.
   PubMed Web of Science ®Google Scholar
• Gagnon AM, Chabot J., Pardasani D, et al. Extracellular matrix induced by TGFb impairs insulin signal transduction in 3T3-L1 preadipose cells. J Cell Physiol 1998; in press.
   Google Scholar